Efficacy and safety of retreatment with vedolizumab in patients with ulcerative colitis

被引：0
|
作者：
Sands, B. E. [1 ]
Shafran, I. [2 ]
Farraye, F. A. [3 ]
Cheifetz, A. S. [4 ]
Abhyankar, B. [5 ]
Sankoh, S. [6 ]
Smyth, M. [7 ]
机构：
[1] Mt Sinai Hosp, Icahn Sch Med, Gastroenterol, New York, NY 10029 USA
[2] Shafran Gastroenterol Ctr, Gastroenterol, Winter Pk, FL USA
[3] Boston Med Ctr, Gastroenterol, Boston, MA USA
[4] Beth Israel Deaconess Med Ctr, Med, Boston, MA 02215 USA
[5] Takeda Global Res & Dev Ctr Europe Ltd, Clin Sci, London, England
[6] Takeda Pharmaceut Int Co, Stat, Cambridge, MA USA
[7] Takeda Global Res & Dev Ctr Europe Ltd, Med, London, England
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP028
引用
收藏
页码：S37 / S37
页数：1
相关论文
共 50 条
  • [11] Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
    Ooi, Choon Jin
    Hilmi, Ida Normiha
    Kim, Hyo-Jong
    Jalihal, Umesh
    Wu, Deng-Chyang
    Demuth, Dirk
    Lindner, Dirk
    Adsul, Shashi
    INTESTINAL RESEARCH, 2021, 19 (01) : 71 - +
  • [12] Efficacy and Safety of Induction Therapy With Calcineurin Inhibitors in Combination With Vedolizumab in Patients With Refractory Ulcerative Colitis
    Pellet, Gauthier
    Stefanescu, Carmen
    Carbonnel, Franck
    Peyrin-Biroulet, Laurent
    Roblin, Xavier
    Allimant, Christophe
    Nachury, Maria
    Nancey, Stephane
    Filippi, Jerome
    Altwegg, Romain
    Brixi, Hedia
    Fotsing, Ginette
    de Rosamel, Laure
    Shili, Sarah
    Laharie, David
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (03) : 494 - 501
  • [13] EFFICACY AND SAFETY OF VEDOLIZUMAB SUBCUTANEOUS FORMULATION FOR ULCERATIVE COLITIS: RESULTS OF THE VISIBLE TRIAL
    Sandborn, W. J.
    Baert, F.
    Danese, S.
    Krznaric, Z.
    D'Haens, G.
    Kobayashi, T.
    Yao, X.
    Chen, J.
    Kisfalvi, K.
    Vermeire, S.
    GUT, 2019, 68 : A60 - A60
  • [14] Efficacy and Safety of Vedolizumab in Management of Moderate to Severe Ulcerative Colitis: A Systematic Review
    Bhandari, Renu
    Ogeyingbo, Opemipo D.
    Kareem, Roaa
    Gyawali, Mallika
    Venkatesan, Nanditha
    Ahmed, Rowan
    Botleroo, Rinky A.
    Elshaikh, Abeer O.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [15] Efficacy and Safety of Vedolizumab With Advancing Age in Patients With Ulcerative Colitis: Results From the GEMINI 1 Study
    Yajnik, Vijay
    Khan, Nabeel
    Dubinsky, Marla
    Axler, Jeffrey L.
    Green, Alexandra
    Abhyankar, Brihad
    Lasch, Karen
    GASTROENTEROLOGY, 2015, 148 (04) : S278 - S279
  • [16] Comparative Efficacy and Safety of Ozanimod vs Adalimumab and Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis
    Dubinsky, Marla C.
    Betts, Keith A.
    LaPensee, Kenneth
    Eren, Devrim
    Kim-Romo, Dawn
    Yin, Lei
    Tang, Wenxi
    Gupte-Singh, Komal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S314 - S314
  • [17] A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis
    Peyrin-Biroulet, L.
    Arkkila, P.
    Armuzzi, A.
    Atreya, R.
    Danese, S.
    Ferrante, M.
    Guardiola, J.
    Jahnsen, J.
    Louis, E.
    Lukas, M.
    Reinisch, W.
    Roblin, X.
    Smith, P. J.
    Kwon, T. S.
    Kim, J. Y.
    Yoon, S. W.
    Kim, D. H.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I1116 - I117
  • [18] Efficacy and safety of a new vedolizumab subcutaneous formulation in Japanese patients with moderately to severely active ulcerative colitis
    Kobayashi, Taku
    Ito, Hiroaki
    Ashida, Toshifumi
    Yokoyama, Tadashi
    Nagahori, Masakazu
    Inaba, Tomoki
    Shikamura, Mitsuhiro
    Yamaguchi, Takayoshi
    Hori, Tetsuharu
    Pinton, Philippe
    Watanabe, Mamoru
    Hibi, Toshifumi
    INTESTINAL RESEARCH, 2021, 19 (04) : 448 - +
  • [19] Efficacy and safety of vedolizumab with advancing age in patients with ulcerative colitis: Results from the GEMINI 1 study
    Yajnik, V.
    Khan, N.
    Dubinsky, M.
    Axler, J.
    Green, A.
    Abhyankar, B.
    Lasch, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S363 - S364
  • [20] Long-Term Efficacy of Vedolizumab Therapy for Patients With Ulcerative Colitis
    Feagan, Brian
    Kaser, Arthur
    Smyth, Michael
    Panaccione, Remo
    Sankoh, Serap
    Abhyankar, Brihad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2014, 109 : S477 - S478
12345